End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.27 MYR | +0.32% | +2.45% | +3.98% |
Apr. 05 | IHH Healthcare Names CFO | MT |
Apr. 05 | IHH Healthcare Berhad Appoints Dilip Kadambi as Group Chief Financial Officer | CI |
Strengths
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- With an expected P/E ratio at 31.52 and 28.84 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+3.98% | 11.58B | B+ | ||
-20.16% | 16.21B | B+ | ||
+4.50% | 12.44B | B | ||
+9.72% | 10.79B | B+ | ||
+23.61% | 8.26B | B | ||
-2.19% | 7.68B | A- | ||
+20.75% | 7.2B | D | ||
+4.49% | 6.67B | B- | ||
+50.89% | 4.66B | - | ||
-5.01% | 4.25B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- IHH Stock
- Ratings IHH Healthcare